Latest Hepatitis B in China Stories
Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
Small financial incentives, totaling as little as £30, can dramatically increase the likelihood of people who inject drugs completing a course of hepatitis B virus (HBV) vaccination.
XIANYANG, China, Jan. 15, 2014 /PRNewswire/ -- Biostar Pharmaceuticals, Inc.
Exciting new data presented today at the International Liver Congress™ 2013 include results from early in vitro and in vivo studies targeting covalently closed circular DNA (cccDNA), which may form the basis of a cure for chronic hepatitis B virus (HBV) infection.
A towering $60,000 bill, a year of fierce, flu-like symptoms and a running risk of depression are among the possible costs of two new hepatitis C treatments.
TALLAHASSEE, Fla., July 28, 2011 /PRNewswire/ -- Marking World Hepatitis Day, the Hepatitis Education Awareness & Liver Support of the South represents hepatitis patients and caregivers from across the Southeast in the nation's Capitol today. Promoting education and awareness, H.E.A.L.S.
- A gift; a largess; a gratuity; a present; a dole.